Dimensional Fund Advisors LP Tricida, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$8.51 - $13.6 $120,782 - $193,024	-14,193 Reduced 29.22%	34,386 $360,000
Q4 2021 Feb 09, 2022	SELL	$4.19 - $9.56 $3,352 - $7,648	-800 Reduced 1.62%	48,579 $464,000
Q3 2021 Nov 12, 2021	BUY	$3.56 - $4.64 $61,883 - $80,657	17,383 Added 54.33%	49,379 $229,000
Q2 2021 Aug 12, 2021	BUY	$3.95 - $5.41 $25,224 - $34,548	6,386 Added 24.94%	31,996 $138,000
Q1 2021 May 14, 2021	BUY	$4.52 - $7.8 $115,757 - $199,758	25,610 New	25,610 $135,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.